Skip to main content
Staff Login
Username
*
Enter your The Contraceptive Pipeline Database username.
Password
*
Enter the password that accompanies your username.
Log in
Forgot password
Toggle navigation
FemBloc Permanent Contraceptive System
Product Overview
Development Status:
Active Development
Target:
Female
Mode:
Non-hormonal
Delivery Type:
Intrauterine
Duration Type:
Permanent
Description:
A degradable biopolymer is sent through a catheter-based delivery system placed in the uterus to permanently block the fallopian tubes after several weeks.
Updated date:
May 30, 2018
Vertical Tabs
Product Details
Potential Multi-Purpose Technology (MPT):
No
Duration:
permanent
Partner:
Femsays Inc
Status
Project Phase:
Early Development
Project Stage:
Phase I
Status Details:
IDE approval granted by FDA in 2016 for U.S. prospective, multi-center clinical trial of FemBloc beginning in early 2017.
Programmatic Considerations
Considerations:
Does not require specialized surgical skills or investment in costly surgical equipment
Additional Information
Additional Information:
Famsays website:
http://www.femasys.com/
Download Product Report
